UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation

Hematology, Transfusion and Cell Therapy, 2023-10, Vol.45 (4), p.510-512

2023

Volltextzugriff (PDF)

Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study

Leukemia, 2022-03, Vol.36 (3), p.856-864

2022

Volltextzugriff (PDF)

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options

Transfusion (Philadelphia, Pa.), 2015-02, Vol.55 (2), p.452-458

2015

Volltextzugriff (PDF)

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration

Haematologica (Roma), 2023-12, Vol.108 (12), p.3321-3332

2023

Volltextzugriff (PDF)

Pre‐clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice

Transfusion (Philadelphia, Pa.), 2019-12, Vol.59 (12), p.3698-3713

2019

Volltextzugriff (PDF)

Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host

Hematology, Transfusion and Cell Therapy, 2021-10, Vol.43 (4), p.507-511

2021

Volltextzugriff (PDF)

Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies

HemaSphere, 2021-04, Vol.5 (4), p.e549-n/a

2021

Volltextzugriff (PDF)

682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A774-A774

2023

Volltextzugriff (PDF)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation

Hematology, transfusion and cell therapy, 2023-12, Vol.45 (4), p.510-512

2023

Volltextzugriff (PDF)

Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum

JAAD Case Reports, 2020-06, Vol.6 (6), p.567-568

2020

Volltextzugriff (PDF)

Autoimmune hematologic complications of umbilical cord blood transplantation

Hematology/oncology and stem cell therapy, 2021-06, Vol.14 (2), p.104-109

2021

Volltextzugriff (PDF)

Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis

Leukemia research reports, 2015, Vol.4 (1), p.36-38

2015

Volltextzugriff (PDF)

The Case | Proteinuria in a patient with hematopoietic stem cell transplantation

Kidney international, 2021-05, Vol.99 (5), p.1249-1250

2021

Volltextzugriff (PDF)

MPN-452 ALLogeneic Stem Cell Transplant in Myelofibrosis Patients: A Real-World Analysis

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S433-S433

2024

Volltextzugriff (PDF)

Allogeneic Stem Cell Transplant in Myelofibrosis Patients: A Real-World Analysis

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S205-S205

2024

Volltextzugriff (PDF)

Initial Results of a Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Prevent Relapse after Allogeneic Hematopoietic Cell Transplantation

Blood, 2023-11, Vol.142 (Supplement 1), p.2090-2090

2023

Volltextzugriff (PDF)

Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes

Transplantation proceedings, 2023-10, Vol.55 (8), p.1799-1809

2023

Volltextzugriff (PDF)

Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement

Blood, 2022-11, Vol.140 (Supplement 1), p.11618-11620

2022

Volltextzugriff (PDF)

Prognostic Impact of Day 14 Bone Marrow (D14 BM Bx) in Acute Myeloid Leukemia (AML) in the Setting of European Leukemianet (ELN) Risk Classification

Blood, 2022-11, Vol.140 (Supplement 1), p.139-140

2022

Volltextzugriff (PDF)

A phase 1 trial of TSC-100 and TSC-101, engineered T cell therapies that target minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS2678-TPS2678

2024

Volltextzugriff (PDF)

Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm

Leukemia research, 2020-11, Vol.98, p.106456, Article 106456

2020

Volltextzugriff (PDF)

Implementing clinical decision support for oncology advanced care planning: A systems engineering framework to optimize the usability and utility of a machine learning predictive model in clinical practice

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.330-330

2021

Volltextzugriff (PDF)

Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia

American journal of hematology, 2024-10, Vol.99 (10), p.2026-2028

2024

Volltextzugriff (PDF)

Dose-Adjusted Intensive Chemotherapy Is Safe and Tolerable in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.5158-5158

2018

Volltextzugriff (PDF)

Human-centered design to improve clinical decision support systems (CDSS) to engage in serious illness communication (SIC) with patients with cancer in a gastrointestinal oncology clinic

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.433-433

2022

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(57)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Hematology
(15)
Humans
(11)
Hematology, Oncology And Palliative Medicine
(10)
Transplantation
(8)
Middle Aged
(7)
Female
(6)
Immunology
(6)
Myelofibrosis
(5)
Oncology
(5)
Adult
(4)
Aged
(4)
Case Report
(4)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(4)
Male
(4)
Retrospective Studies
(4)
Hematopoietic Stem Cell Transplantation - Methods
(3)
Splenomegaly
(3)
Stem Cell Transplantation
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation

Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration

Pre‐clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice

Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host

Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies

682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation

Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum

Autoimmune hematologic complications of umbilical cord blood transplantation

Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis

The Case | Proteinuria in a patient with hematopoietic stem cell transplantation

MPN-452 ALLogeneic Stem Cell Transplant in Myelofibrosis Patients: A Real-World Analysis

Allogeneic Stem Cell Transplant in Myelofibrosis Patients: A Real-World Analysis

Initial Results of a Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Prevent Relapse after Allogeneic Hematopoietic Cell Transplantation

Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes

Central Nervous System Specific Characteristics and Outcomes in Acute Myeloid Leukemia Patients with Neurologic Involvement

Prognostic Impact of Day 14 Bone Marrow (D14 BM Bx) in Acute Myeloid Leukemia (AML) in the Setting of European Leukemianet (ELN) Risk Classification

A phase 1 trial of TSC-100 and TSC-101, engineered T cell therapies that target minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation

Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm

Implementing clinical decision support for oncology advanced care planning: A systems engineering framework to optimize the usability and utility of a machine learning predictive model in clinical practice

Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia

Dose-Adjusted Intensive Chemotherapy Is Safe and Tolerable in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia

Human-centered design to improve clinical decision support systems (CDSS) to engage in serious illness communication (SIC) with patients with cancer in a gastrointestinal oncology clinic

Suchergebnisse filtern